{"id":403169,"date":"2020-12-18T18:46:19","date_gmt":"2020-12-18T23:46:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403169"},"modified":"2020-12-18T18:46:19","modified_gmt":"2020-12-18T23:46:19","slug":"shattuck-labs-added-to-russell-2000-and-3000-indexes","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/","title":{"rendered":"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">AUSTIN, TX and DURHAM, NC, Dec.  18, 2020  (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced that it will be added to the Russell 2000\u00ae and 3000\u00ae Indexes effective December 21, 2020, following Russell\u2019s quarterly additions of select initial public offerings.<\/p>\n<p>&#8220;We are incredibly pleased to be included in the Russell 2000\u00ae and Russell 3000\u00ae Indexes,&#8221; said\u00a0Andrew Neill, Shattuck\u2019s Vice President of Finance and Corporate Strategy. &#8220;This milestone reflects the potential that investors see in Shattuck. Importantly, it increases our visibility in the investment community while broadening our institutional shareholder base.&#8221;<\/p>\n<p>Russell indexes are part of FTSE Russell, a leading global index provider. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell\u2019s US indexes.<\/p>\n<p>\n        <strong>About Shattuck Labs, Inc.<\/strong><br \/>\n        <br \/>Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck\u2019s proprietary Agonist Redirected Checkpoint, ARC<sup>\u00ae<\/sup>, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company\u2019s lead wholly owned program, SL-172154 (SIRP\u03b1-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with\u00a0Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLEN\u2122, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both\u00a0Austin, Texas and Durham, North Carolina. For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MoZL6HjdzCIUVKOArMM-wRsfNfwL4qaYvcU5sUDYv0gkQ-EU6h_20O4XtqjL2WMvirXQcRF78H34-0sjLZgq2-hndoxvCSiDGCMfLCCLzCY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ShattuckLabs.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Conor Richardson<br \/>Senior Director, Finance &amp; Investor Relations <br \/>Shattuck Labs, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rBd46PQZ5C7ftRzi0QfLyQ-V7P0LyHAxuaSlR1DstKxOPwMAjGBYSZYpCAggw1X85t89IhTFZo0v5BRgkFFOaUx_u9Nh7Uq3Dkc9OGwm5PcGy527rfRcQU5XPUkPsz7LbZ1_DaHyvebLASkYZXRzPg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">InvestorRelations@shattucklabs.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Stephanie Ascher <br \/>Managing Director<br \/>Stern Investor Relations, Inc.<br \/>Stephanie.ascher@sternir.com<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b2061e3b-f4eb-4814-91f1-ea756e2cb090\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, TX and DURHAM, NC, Dec. 18, 2020 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced that it will be added to the Russell 2000\u00ae and 3000\u00ae Indexes effective December 21, 2020, following Russell\u2019s quarterly additions of select initial public offerings. &#8220;We are incredibly pleased to be included in the Russell 2000\u00ae and Russell 3000\u00ae Indexes,&#8221; said\u00a0Andrew Neill, Shattuck\u2019s Vice President of Finance and Corporate Strategy. &#8220;This milestone reflects the potential that investors see in Shattuck. Importantly, it increases our visibility in the investment community while broadening our institutional shareholder &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403169","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, TX and DURHAM, NC, Dec. 18, 2020 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced that it will be added to the Russell 2000\u00ae and 3000\u00ae Indexes effective December 21, 2020, following Russell\u2019s quarterly additions of select initial public offerings. &#8220;We are incredibly pleased to be included in the Russell 2000\u00ae and Russell 3000\u00ae Indexes,&#8221; said\u00a0Andrew Neill, Shattuck\u2019s Vice President of Finance and Corporate Strategy. &#8220;This milestone reflects the potential that investors see in Shattuck. Importantly, it increases our visibility in the investment community while broadening our institutional shareholder &hellip; Continue reading &quot;Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-18T23:46:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes\",\"datePublished\":\"2020-12-18T23:46:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/\"},\"wordCount\":357,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/\",\"name\":\"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=\",\"datePublished\":\"2020-12-18T23:46:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-added-to-russell-2000-and-3000-indexes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/","og_locale":"en_US","og_type":"article","og_title":"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes - Market Newsdesk","og_description":"AUSTIN, TX and DURHAM, NC, Dec. 18, 2020 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced that it will be added to the Russell 2000\u00ae and 3000\u00ae Indexes effective December 21, 2020, following Russell\u2019s quarterly additions of select initial public offerings. &#8220;We are incredibly pleased to be included in the Russell 2000\u00ae and Russell 3000\u00ae Indexes,&#8221; said\u00a0Andrew Neill, Shattuck\u2019s Vice President of Finance and Corporate Strategy. &#8220;This milestone reflects the potential that investors see in Shattuck. Importantly, it increases our visibility in the investment community while broadening our institutional shareholder &hellip; Continue reading \"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-18T23:46:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes","datePublished":"2020-12-18T23:46:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/"},"wordCount":357,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/","name":"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=","datePublished":"2020-12-18T23:46:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTEzMCMzODg5Mzc1IzIyMDI4MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-added-to-russell-2000-and-3000-indexes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shattuck Labs Added to Russell 2000\u00ae and 3000\u00ae Indexes"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403169"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403169\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}